Hopkin RJ - Search Results

1

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR. Eng CM, et al. Among authors: hopkin rj. Genet Med. 2006 Sep;8(9):539-48. doi: 10.1097/01.gim.0000237866.70357.c6. Genet Med. 2006. PMID: 16980809 Free article. Review.

2

Comparative evaluation of alpha-galactosidase A infusions for treatment of Fabry disease.

Hopkin RJ, Bissler J, Grabowski GA. Hopkin RJ, et al. Genet Med. 2003 May-Jun;5(3):144-53. doi: 10.1097/01.GIM.0000069509.57929.CD. Genet Med. 2003. PMID: 12792421 Review.

3

Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease.

Street NJ, Yi MS, Bailey LA, Hopkin RJ. Street NJ, et al. Among authors: hopkin rj. Genet Med. 2006 Jun;8(6):346-53. doi: 10.1097/01.gim.0000223545.63012.5a. Genet Med. 2006. PMID: 16778596 Free article.

4

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.

Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, Sims K, Waldek S, Pastores GM, Lee P, Eng CM, Marodi L, Stanford KE, Breunig F, Wanner C, Warnock DG, Lemay RM, Germain DP; Fabry Registry. Wilcox WR, et al. Among authors: hopkin rj. Mol Genet Metab. 2008 Feb;93(2):112-28. doi: 10.1016/j.ymgme.2007.09.013. Epub 2007 Nov 26. Mol Genet Metab. 2008. PMID: 18037317

5

Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry.

Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain DP, Lemay R, Tylki-Szymanska A, Wilcox WR. Hopkin RJ, et al. Pediatr Res. 2008 Nov;64(5):550-5. doi: 10.1203/PDR.0b013e318183f132. Pediatr Res. 2008. PMID: 18596579

6

Fabry's disease.

Zarate YA, Hopkin RJ. Zarate YA, et al. Among authors: hopkin rj. Lancet. 2008 Oct 18;372(9647):1427-35. doi: 10.1016/S0140-6736(08)61589-5. Lancet. 2008. PMID: 18940466 Review.

7

A case of minimal change disease in a Fabry patient.

Zarate YA, Patterson L, Yin H, Hopkin RJ. Zarate YA, et al. Among authors: hopkin rj. Pediatr Nephrol. 2010 Mar;25(3):553-6. doi: 10.1007/s00467-009-1353-0. Epub 2009 Oct 30. Pediatr Nephrol. 2010. PMID: 19876652

8

Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry.

Watt T, Burlina AP, Cazzorla C, Schönfeld D, Banikazemi M, Hopkin RJ, Martins AM, Sims K, Beitner-Johnson D, O'Brien F, Feldt-Rasmussen U. Watt T, et al. Among authors: hopkin rj. Genet Med. 2010 Nov;12(11):703-12. doi: 10.1097/GIM.0b013e3181f13a4a. Genet Med. 2010. PMID: 20885332 Free article.

9

Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy.

Forsha D, Li JS, Smith PB, van der Ploeg AT, Kishnani P, Pasquali SK; Late-Onset Treatment Study Investigators. Forsha D, et al. Genet Med. 2011 Jul;13(7):625-31. doi: 10.1097/GIM.0b013e3182142966. Genet Med. 2011. PMID: 21543987 Free PMC article. Clinical Trial.

10

Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors.

Laney DA, Bennett RL, Clarke V, Fox A, Hopkin RJ, Johnson J, O'Rourke E, Sims K, Walter G. Laney DA, et al. Among authors: hopkin rj. J Genet Couns. 2013 Oct;22(5):555-64. doi: 10.1007/s10897-013-9613-3. Epub 2013 Jul 17. J Genet Couns. 2013. PMID: 23860966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page